MP07-17 CLINICAL VALIDATION OF A LIVE-CELL PHENOTYPIC BIOMARKER - BASED DIAGNOSTIC ASSAY FOR THE PREDICTION OF ADVERSE PATHOLOGY IN PROSTATE CANCER